Outcomes and complications reported from a multiuser canine hip replacement registry over a 10-year period.

Abstract

To report outcomes and complications associated with total hip replacements (THR) using a multiuser canine hip registry (CHR) and owner-administered questionnaire. Prospective longitudinal clinical study. Dogs (n = 1852). Total hip replacement cases submitted to a CHR were reviewed. An online questionnaire including an adapted "Liverpool Osteoarthritis in Dogs" (LOAD) score was e-mailed to owners. Data were analyzed to determine associations between clinical variables and the agreement by veterinary surgeons and owners for complications. A group of 1329 (72%) dogs had unilateral THRs and another group of 523 (28%) dogs had bilateral THRs, resulting in 2375 THRs. Indications included hip dysplasia and osteoarthritis (n=2028/2375, 85%). Implants were manufactured by Kyon (n =1087, 46%), BioMedtrix CFX (n=514, 22%), BioMedtrix hybrid (n=264, 11%), BioMedtrix BFX (n=221, 9%), and Helica (n=107, 4.5%). Median veterinary surgeon and owner follow up were 1328 and 900 days respectively. Postoperative LOAD scores (21 ± 9) reported by 461 owners improved compared to preoperative scores (11 ± 9) (P < .001). Veterinary surgeons reported complications in 201/2375 (8.5%) THRs and owners in 107/461 (23%) THRs, with moderate agreement (weighted kappa=0.44). No associations were identified between complications and weight, age, sex, or breed. BioMedtrix BFX and Helica implants were associated with increased complications (P=.031) when used for revisions of femoral head and neck excisions. Excellent outcomes, including improved canine mobility, were reported after THRs. Complications were underreported by veterinary surgeons compared to owners in this first multiuser CHR. Canine THRs are safe, effective procedures but THR implants should be carefully selected when revising femoral head and neck excisions.